West Bancorporation’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
West Bancorporation's PFE Position: Q3 2026 in Review
West Bancorporation reduced its Pfizer (PFE) stake by 19% in Q3 2026, selling an estimated $89.8K and leaving 14,600 shares worth $416K. The position accounts for 0.16% of the portfolio, ranked #64.
West Bancorporation first reported a position in PFE in Q4 2019 and has held it in 24 quarters since. The position peaked at $1.67M in Q2 2022. 2,002 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- West Bancorporation held 14,600 shares of Pfizer worth $416K as of Q3 2026.
- West Bancorporation sold 3,375 Pfizer shares in Q3 2026, an estimated $89.8K.
- Pfizer made up 0.16% of West Bancorporation's portfolio in Q3 2026, its #64 holding.
- West Bancorporation first reported a position in Pfizer in Q4 2019 and has held it in 24 quarters since.
- West Bancorporation's Pfizer position peaked at $1.67M in Q2 2022.
- 2,002 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on West Bancorporation's 13F filing for Q3 2026, filed 29 Oct 2026.